Superselective angio-CT of brain tumors

AJNR Am J Neuroradiol. 1996 Jun-Jul;17(6):1073-80.

Abstract

Purpose: To determine the efficacy of superselective angio-CT in the diagnosis of astrocytoma.

Methods: Nineteen patients with astrocytoma had superselective angio-CT before chemotherapeutic agents were administered via superselective intraarterial infusion. CT was performed after contrast material was delivered through a microcatheter, which had been advanced into the feeding arteries of the tumor. Superselective angio-CT scans were compared with digital subtraction angiograms, conventional contrast-enhanced CT scans, and contrast-enhanced T1-weighted MR images.

Results: Superselective angio-CT scans depicted contrast enhancement of the tumor in all of the patients and the medullary veins of the tumors in 32% of the patients. Digital subtraction angiograms showed tumor stains in 68% of the patients and the medullary veins in only 5%. Conventional CT scans and MR images showed contrast enhancement of the tumor in 89% of the patients. Superselective angio-CT scans confirmed the proper position of the catheter tip for the infusion of a chemotherapeutic agent.

Conclusions: Superselective angio-CT can be used to depict contrast enhancement of tumors and the vascular structures that are characteristic of astrocytomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angiography, Digital Subtraction / instrumentation*
  • Antineoplastic Agents / administration & dosage
  • Astrocytoma / blood supply*
  • Astrocytoma / drug therapy
  • Basal Ganglia / blood supply
  • Brain Neoplasms / blood supply*
  • Brain Neoplasms / drug therapy
  • Catheters, Indwelling
  • Cerebellum / blood supply
  • Cerebral Cortex / blood supply
  • Female
  • Glioblastoma / blood supply*
  • Glioblastoma / drug therapy
  • Humans
  • Image Processing, Computer-Assisted
  • Infusions, Intra-Arterial / instrumentation
  • Male
  • Middle Aged
  • Nimustine / administration & dosage
  • Tomography, X-Ray Computed / instrumentation*

Substances

  • Antineoplastic Agents
  • Nimustine